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Rheumatoid arthritis (RA) is a systemic inﬂammatory disease affecting articular and extra-articular
tissues. In this case report, we report a 53-year-old man initially referred to the pulmonary clinic for
dyspnea, new left-sided pleural effusion, and anasarca. After evaluation, he was diagnosed with rheu-
matoid arthritis and RA-associated lung disease. Although pleuropulmonary ﬁndings usually develop in
the setting of known RA, this case displays classic ﬁndings that preceded the onset of musculoskeletal
symptoms and led to the diagnosis.
Published by Elsevier Ltd.1. Initial presentation
Six months prior to pulmonary evaluation, the patient pre-
sented to his internist with dyspnea on exertion, swelling, and dry
cough. Inhaled beta-agonists provided little improvement, and
subsequently over 12 weeks, he developed progressive shortness
of breath, orthopnea, pleuritic pain, and several systemic
complaints including fatigue, night sweats, and weight loss of
twenty pounds. He thereafter had the onset of musculoskeletal
symptoms, speciﬁcally noting pain, stiffness, and swelling in his
wrists, knuckles, and knees bilaterally. The patient’s dyspnea
progressed, precluding him from working and taking part in his
normal activities. His past medical history included hypertension
and tobacco abuse. A full history including exposure history was
otherwise negative.
On initial examination, oxygen saturation was 96% on room air,
vital signs otherwise were normal. He appeared older than his
stated age, and had difﬁculty ambulating due to both dyspnea as
well as joint pain. Lung examination revealed decreased breath
sounds at the left base with dullness to percussion. Musculo-
skeletal examination revealed decreased range of motion at
several joint groups including bilateral wrists and elbows. He had
tender swelling of the left second PIP joint, and two non-tender
nodules on the left MCP joints. The remainder of his examination
was normal.: þ1 434 924 9682.2. Diagnostic studies
2.1. Laboratory studies/imaging
Initial basic labs revealed a normal white blood cell count but
14.4% eosinophils, along with thrombocytosis with a platelet count
of 466 K/mL. Other basic labs were normal. Chest X-ray revealed
moderate sized left pleural effusion without parenchymal abnor-
malities. Pulmonary function tests (PFTs) demonstrated restrictive
lung disease with diffusion impairment (Table 1). Given the clinical
pictures including pulmonary/musculoskeletal symptoms and
restrictive lung disease, underlying rheumatologic diseases were
considered, and immunologic lab tests were performed as a part of
initial evaluation (Table 2). RF and anti-CCP were both strongly
positive and suggestive of sero-positive rheumatoid arthritis.2.2. Diagnostic procedures
A non-contrast CT of the chest with high resolution cuts (CT)
was performed to further evaluate lung parenchyma, and it
demonstrated left-sided moderate pleural effusion without any
evidence of interstitial ﬁbrosis or ground glass opacity (Fig. 1A).
Multiple pleural based, cavitating nodules were seen (Fig. 1B).
Thoracentesis conﬁrmed that the pleural effusion was exudative
with 6.9 g/dL ﬂuid total protein (serum 7.5 g/dL) and 8750 units/L
LDH. Glucose was also markedly low at <5 mg/dL. Total WBC count
was 1300/mL, but cells were too degraded to be assessed for
differential count. Cytology (Fig. 2A and B) demonstrated abundant
granular/necrotic debris, multinucleated giant cells, and rare
spindled histiocytes without any evidence of malignancy which are
Table 2
Immunologic lab tests.
Lab test Result Normal value
ESR 94 mm/h <15 mm/h
Hi-sens CRP 92.9 mg/L <3 mg/L
Rheumatoid Factor (RF) 1100 IU/mL <30 IU/mL
anti-CCP 105 units <20 units
Table 1
PFT demonstrated restrictive process with diffusion impairment.
Test Result %Predicted
Forced Expiratory Volume in 1 s (FEV1) 2.24 (L) 53%
Forced Vital Capacity (FVC) 3.04 (L) 56%
FEV1/FVC ratio 73.8
Diffusion Capacity (DLCO) 19.4 (L) 59%
Total Lung Capacity (TLC) 4.38 (L) 57%
Residual Volume (RV) 1.39 (L) 60%
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acid fast and fungal stains were negative, and all subsequent
cultures were negative at 2-month time point. Along with the rest
of the clinical pictures, the biochemical ﬁndings/cytology sup-
ported the diagnosis of rheumatoid pleuritis/lung disease.3. Discussion
RA is a generally progressive systemic inﬂammatory disorder
characterized by chronic, symmetrical synovitis. In addition, RA is
characterized by extra-articular manifestations. Our patient pre-
sented with a constellation of features concerning for RA with
associated pleuropulmonary disease.
While pleuropulmonary disease is common in RA, it is often
under recognized, and as in our patient delay in diagnosis is
common. Althoughmany times disease can be sub-clinical, autopsy
studies suggest the prevalence of pleuropulmonary ﬁndings in RA
to be 40–70%.1–3 Radiographic and/or physiologic pulmonary
abnormalities are common. Saag et al. found 32.4% of patients with
known RA to have either an abnormal chest X-ray consistent with
RA-associated disease or restrictive pulmonary physiology deﬁned
by an FVC< 80% predicted or a DLCO< 80% predicted.4 Other
authors similarly comment on the high prevalence of pleuro-
pulmonary disease and suggest heightened awareness.3,5
Our patient ﬁt into the classic demographic for lung disease in
RA. Risk factors are age> 35, smoking history, severe arthritis,
other extra-articular disease, presence of rheumatoid nodules, and
positive RF with high titers.1,4–6 Male sex is also thought to be a risk
factor. Although RA in general is more common in women, it is
estimated that men are affected by RA-associated interstitial lungFig. 1. Panel A – moderate left-sided pleural effudisease (ILD) roughly twice as frequently. For pleural disease, about
80% of cases are men.
Pleuropulmonary disease is often sub-clinical with symptoms
developing years after articular symptoms, or changes discovered
incidentally on radiographs or autopsy. Patients may limit activity
due to joint disease, in turn putting less stress on the pulmonary
system and limiting symptoms. When present, respiratory symp-
toms usually develop in the setting of known RA. Our case is unique
because respiratory complications precede the diagnosis.6 It is
estimated that respiratory symptoms coincide with or precede the
onset of musculoskeletal symptoms in 5–25% of cases of RA-asso-
ciated lung disease.2,3,5
The most common forms of RA-associated lung disease
include pleural disease, nodules, and interstitial lung disease
(ILD).1,5,7 Our patient was initially referred for respiratory
symptoms in the setting of new/unexplained pleural effusion.
This is a relatively common condition in RA, with symptoms
likely present in 3–5% and radiographic evidence of effusion in
16–24% of patients with RA.5,8 Dyspnea, pleuritic pain, and fever
are the most commonly reported symptoms.5 Severe symptoms
without large effusions should prompt evaluation for underlying
parenchymal disease that is seen in about one third of patients
with pleural disease.5
Even with a classic clinical picture, pleural ﬂuid evaluation with
thoracentesis is essential. Rheumatoid pleural effusions are
invariably exudates, with classic features listed in Table 3.1,5
Our patient’s ﬂuid analysis ﬁt well with RA, which was our
leading diagnosis. Initial differential diagnosis included mycobac-
terial infection, malignancy, and chronic empyema. Cytology added
diagnostic speciﬁcity for rheumatoid pleuritis by demonstrating
the triad of slender, elongated macrophages, round multinucleated
giant cells, and necrotic background material. Some authors
suggest that this triad is highly speciﬁc and even pathognomonic of
rheumatoid disease, even in the absence of arthritis.3,9–11 Given his
clinical picture, cytology in our patient’s case (Fig. 2A and B) sup-
ported the diagnosis of RA.
In addition to pleural disease, the patient’s two other major
ﬁndings were the cavitary, subpleural nodules and the PFT abnor-
malities. The nodules seen on CT were typical of those seen in 20–
30% patients with RA, which are usually in subpleural location or
along interlobular septa.1,12,13 Nodules in RA are often asymptom-
atic, and their courses alone are usually benign.8 Occasionally
nodules can cavitate, and the subpleural location can account for
complications including pleural effusion, pneumothorax, pyop-
neumothorax, and bronchopleural ﬁstula.1 The differential diag-
nosis for RA-associated nodules parallels the differential in the
general population and should include malignancy, infection, and
other inﬂammatory disease. In his case the appropriate measures
were taken to rule out other etiologies, and given his clinical picture
this was the most likely diagnosis.sion, Panel B – cavitating peripheral nodule.
Fig. 2. Panel A – pleural ﬂuid cytology showing features suggestive of rheumatoid pleuritis.
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usually associated with nodules, we must consider the patient’s
restrictive lung disease and diffusion impairment as a major
contributor to his symptoms. PFT abnormalities in RA are common
and may represent sensitive markers of ILD. Reductions in FVC and
DLCO are the most common, although obstructive disease can also
be seen.4,12,13 Saag et al. found that 13% of a random group of RA
patients had FVC values <80% predicted, and 19% had DLCO values
<80% predicted.4 These abnormalities have been seen even in early
RA. One study of RA patients with general symptoms of duration
less than 2 years found 11% of patients with RA< 2 years to have
FVC or TLC< 80% predicted, and 33% to have DLCO< 80% pre-
dicted.14 Many of these patients were asymptomatic from a respi-
ratory standpoint. CT ﬁndings are also common, and abnormalities
are found in between 10–46% of all patients with RA. The most
common abnormalities have been found to be ground glass opacity
with reticular abnormalities.15 Interestingly, although his symp-
toms and PFT abnormalities were prominent, our patient did not
have ﬁndings on CT to suggest ILD. This may represent a casewhere
physiologic abnormalities associated with RA have preceded
radiographic changes.4. Follow up/conclusion
Themajor alternative considerations in this case were infectious
or malignant processes. Overall, with his symptoms including
respiratory and musculoskeletal complaints, pertinent laboratory
studies, pleural ﬂuid analysis, and pulmonary function testing, RA-
associated lung disease was our top consideration. Anti-inﬂam-
matory treatment was initially started with indomethacin and
sulfasalazine. Prior to starting more aggressive anti-rheumatic
therapy it was necessary to exclude co-existent infection. PPD as
well as cultures and stains from the pleural ﬂuid remained nega-
tive. The patient was observed closely for 6 weeks, following which
he had symptomatic improvement allowing him to resume fullTable 3
Biochemical ﬁndings in rheumatoid effusions.
Test Value Comments
Total protein >4 g/dL
LDH >700 U/L
Glucose Very low 70% (<40 mg/dL), 40% (<10 mg/dL)
80% (pleural ﬂuid:serum
glucose ratio <0.5)
pH <7.20
WBC 1000–5000/mL Predominance of neutrophils
or lymphocytes
RF Elevated
Adenosine deaminase Elevated
Complement Lowtime working. Given his improvement and culture negativity, an
infectious/malignant process was thought to be unlikely, and
additional anti-rheumatic therapy was initiated. It was felt that he
would not be a candidate for methotrexate given his restrictive
lung disease, and thus leﬂunomide was initiated. At this time we
plan continued monitoring of both his pulmonary and musculo-
skeletal symptoms.
This case illustrates different aspects of pleuropulmonary
disease associated with rheumatoid arthritis. Our patient presented
a diagnostic challenge given that his respiratory symptoms over-
shadowed and preceded musculoskeletal symptoms. Only in
retrospect and with full evaluation of all studies, clear diagnosis
was established.
Heightened awareness of the spectrum of systemic rheumatoid
arthritis must include coexisting pulmonary diseases in the right
clinical settings.
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